Navigation Links
ORNL, UTGSM study compares structures of Huntington's disease protein
Date:7/16/2014

OAK RIDGE, Tenn., July 16, 2014 -- Neutron scattering research at the Department of Energy's Oak Ridge National Laboratory has revealed clear structural differences in the normal and pathological forms of a protein involved in Huntington's disease.

Huntington's disease, an incurable neurodegenerative disorder, starts as a genetic mutation that leads to an overabundance of "huntingtin" protein fragments, which form clumps in the brain.

Valerie Berthelier of the University of Tennessee Graduate School of Medicine, who co-led the study published in Biophysical Journal with ORNL's Chris Stanley, said the goal was to establish a baseline understanding of huntingtin's structure in order to eventually determine the true structural basis of Huntington's disease.

"This is a very first step -- the hope is that we do this basic research to shed light on the structures of the protein," Berthelier said. "If we can start identifying any of these structures as toxic or potentially toxic, and then think about how drugs could interact with them, then we might be getting to the point of rationally designing therapeutics that would target those specific structures."

The researchers conducted a side-by-side study of model protein systems in solution using a time-resolved small-angle neutron scattering technique at ORNL's High Flux Isotope Reactor. The use of neutrons, a non-damaging but highly penetrating particle, allowed the team to study the biological materials over time without degrading the samples' structural integrity.

"We compared the normal and disease versions of the protein to see how they change over time," Stanley said. "You can see there's a discrepancy all the way from the early stages to the end-state fibrils."

The study's results showed key differences in the ways mutant and normal huntingtin proteins take shape. The disease protein, for instance, initially forms aggregates of one to two peptides, whereas the normal version makes bigger aggregates, gathering seven or eight peptides together.

These data on the very early stages of protein aggregate formation support a growing focus of the research in the amyloid field. Amyloid disorders, such as Parkinson's, Alzheimer's and Huntington's, all involve protein aggregation phenomena leading to a disease.

"There is no strong correlation between neuronal cell loss and the amount of protein aggregates found in the brain," Stanley said. "You could have a case with a lot of aggregates but minimal symptoms -- and you can find the converse. Researchers think there must be something happening at the earliest stage that's giving rise to toxicity."

Stanley says the team hopes to continue its research to obtain higher-resolution structural data and refine their understanding of the huntingtin protein.

"We'd like to use this small-angle neutron scattering technique in combination with others to get a better idea for how these early structures are forming and also ask the question -- are they toxic or not?" Stanley said.


'/>"/>

Contact: Morgan McCorkle
mccorkleml@ornl.gov
86-557-407-308
DOE/Oak Ridge National Laboratory
Source:Eurekalert  

Related medicine news :

1. Worm study provides hope for deadly disease of the brain
2. Surgery Soon After Stroke Can Be Risky: Study
3. Stroke Rates Declining Among Seniors, Study Shows
4. Study Warns of Kidney Damage Risk with Popular Mesothelioma Drug, Reports Surviving Mesothelioma
5. Genes May Raise Risk of Cerebral Palsy, Study Finds
6. Transparency lacking in clinical trials, BU study finds
7. Study: Body Dysmorphic Disorder patients have higher risk of personal and appearance-based rejection sensitivity
8. Home Blood Pressure Monitoring Likely Saves Money, Study Finds
9. Kids From Dairy Farms Have Lower Allergy Risk, Study Finds
10. BUSM study: Obesity may be impacted by stress
11. Graphic Cigarette-Label Warnings Work, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ORNL, UTGSM study compares structures of Huntington's disease protein
(Date:5/27/2016)... Texas (PRWEB) , ... May 27, 2016 , ... ... satisfying Army body fat composition regulations. This is the first time that Coolsculpting ... normally screened at least every six months to ensure they meet the prescribed body-fat ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Despite last week’s ... expect Janet Yellen and company to wait until March 2017 for an interest rate ... J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot ...
(Date:5/26/2016)... ... 26, 2016 , ... Georgia State University College of Law ... , Answering to the increasing demand for curricular specializations, the Certificate in Intellectual ... and land use law. ,  , “The demand for lawyers with specific knowledge ...
(Date:5/26/2016)... Franklin, TN (PRWEB) , ... May 26, 2016 , ... ... today, and more than 32 million cancer survivors worldwide. On Sunday, June 5, 2016, ... the 29th annual National Cancer Survivors Day®. , National Cancer Survivors Day® is ...
(Date:5/26/2016)... ... May 26, 2016 , ... In an effort to provide hair restoration information to the widest ... and those who do not use the app. Dr. Mohebi, the founder of Parsa Mohebi ... Mohebi Live . , Dr. Mohebi says, “The positive response to the Snapchat videos ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016  Granger Diagnostics today announced ... for wounds and infections. This test ensures discovery ... select viruses. The test requires only a simple swab ... David G. Bostwick , MD, Chief ... facilitate wound healing: "We are excited to make ...
(Date:5/24/2016)... May 24, 2016 Niederländische ... gebracht, die es Ärzten erlaubt, ihre Expertise weltweit ... MDLinking kombiniert Live Streaming mit einer Instant-Messaging-Funktion und ... kommunizieren. Mediziner in Europa, Afrika, Asien und den ... für die Plattform registriert. Information und ...
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
Breaking Medicine Technology: